Tolerability and Effectiveness of Glucagon-Like Peptide-1 Receptor Agonists in Patients with Inflammatory Bowel Disease
Lindsay Clarke, Ravi Teja Passam, Bryn Falahee, Pichamol Jirapinyo, Jessica R. Allegretti, Colleen Kelly
Topics & Concepts
TolerabilityMedicineHepatologyInflammatory bowel diseaseTransplant surgeryInternal medicineGastroenterologyPharmacologyInflammatory Bowel DiseasesGlucagon-like peptide-2DiseasePeptideAdverse effectChemistryBiochemistryDiabetes Treatment and ManagementInflammatory Bowel DiseaseBariatric Surgery and Outcomes